UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

The expansion forms part of Lilly’s broader $50bn capital investment programme to grow its US manufacturing and production ...

Novartis has reported new results from two ongoing phase 3 trials evaluating ianalumab in patients with Sjögren’s disease, ...

Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...

Today, four out of five HCPs say they’re using LLMs to support clinical decision-making. As these LLM models solidify their ...

Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...

Enterome, a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has announced that the US ...

Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...

Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific ...

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance ...

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications ...